Skip to content
Screener

Jazz Pharmaceuticals JAZZ Acquisition accounting inventory fair value step-up adjustment

Acquisition accounting inventory fair value step-up adjustment at other companies

Globus Medical logo
Globus MedicalGMED
$0-100%
Danaher logo
DanaherDHR
$0
Astec Industries logo
Astec IndustriesASTE
$200K
Astec Industries logo
Astec IndustriesASTE
$200K
Lakeland Industries logo
Lakeland IndustriesLAKE
$0-100%
Haemonetics logo
HaemoneticsHAE
$0-100%

Other financials

Income statement

See full
Revenue$1.1B+19.1%
Operating income$336.6M+702%
Net income$293.1M+417%
EPS (diluted)$4.43+391%

Balance sheet

See full
Cash & equivalents$667.5M-64.1%
Total debt$5.4B-0.1%
Total equity$4.5B+8.6%
Total assets$11.9B+2.8%

Cash flow

See full
Operating cash flow$408.2M-5.0%
CapEx$19.7M+41.7%
Free cash flow$388.5M-6.6%

Valuation

See full
Market cap$16.98B+165%
Enterprise value$21.71B+104%
P/S3.8×+2.3×

Profitability

See full
Operating margin-11.9%-28.1pp
Net margin-8.9%-20.5pp
FCF margin28.6%-8.6pp

Returns & leverage

See full
Return on equity-9.1%-21.2pp
Debt / equity1.2×-0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept jazz:InventoryStepUpValueAdjustment.

The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:09 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001232524-26-000025
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Intangible asset amortization172.3154.4
Share-based compensation74.567.7
Acquisition accounting inventory fair value step-up adjustment37.529.9
Provision for losses on accounts receivable and inventory14.25.3
Depreciation9.110.4
Non-cash interest expense4.717.1
Deferred tax benefit(66.2)(43.8)

Item 1.Financial Statements

FAQ

What is Jazz Pharmaceuticals's acquisition accounting inventory fair value step-up adjustment?
Jazz Pharmaceuticals (JAZZ) reported acquisition accounting inventory fair value step-up adjustment of $37.5M in Q1 2026.
How has Jazz Pharmaceuticals's acquisition accounting inventory fair value step-up adjustment changed year-over-year?
Jazz Pharmaceuticals's acquisition accounting inventory fair value step-up adjustment increased by 25.4% year-over-year, from $29.9M to $37.5M.
What does acquisition accounting inventory fair value step-up adjustment mean?
A non-cash accounting adjustment that increases the carrying value of acquired inventory to its fair value at the time of an acquisition. This adjustment is subsequently expensed as the inventory is sold.

Ask your AI about Jazz Pharmaceuticals's acquisition accounting inventory fair value step-up adjustment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude